Gregory D Davis Sangamo Therapeutics, Inc (SGMO) insider trading activity
Gregory D Davis is Head of Research & Technology of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 201,863 shares of SGMO, which is worth approximately $456,210. The most recent transaction as insider was on Nov 25, 2024, when has been sold 505 shares (Common Stock) at a price of $1.94 per share, resulting in proceeds of $979. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
202K
n/a
3M change
n/a
12M change
Total Value Held
$456,210
Gregory D Davis Transaction History
GDD
Gregory D Davis
Head of Research & Technology
Richmond, CA